These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 18568916)
1. Novel combination of anionic and cationic polymethacrylate polymers for sustained release tablet preparation. Obeidat WM; Abu Znait AH; Sallam AS Drug Dev Ind Pharm; 2008 Jun; 34(6):650-60. PubMed ID: 18568916 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of Matrix Tablets Based on Eudragit®E100/Carbopol®971P Combinations for Controlled Release and Improved Compaction Properties of Water Soluble Model Drug Paracetamol. Obeidat WM; Nokhodchi A; Alkhatib H AAPS PharmSciTech; 2015 Oct; 16(5):1169-79. PubMed ID: 25724162 [TBL] [Abstract][Full Text] [Related]
4. Cationic Eudragit® polymers as excipients for microparticles prepared by solvent evaporation method. Vysloužil J; Bavoľárová J; Kejdušová M; Vetchý D; Dvořáčková K Ceska Slov Farm; 2013 Dec; 62(6):249-54. PubMed ID: 24393112 [TBL] [Abstract][Full Text] [Related]
5. Preparation and characterization of controlled release matrices based on novel seaweed interpolyelectrolyte complexes. Prado HJ; Matulewicz MC; Bonelli PR; Cukierman AL Int J Pharm; 2012 Jun; 429(1-2):12-21. PubMed ID: 22433798 [TBL] [Abstract][Full Text] [Related]
6. Floating and sustained-release characteristics of effervescent tablets prepared with a mixed matrix of Eudragit L-100-55 and Eudragit E PO. Bani-Jaber AK; Alkawareek MY; Al-Gousous JJ; Abu Helwa AY Chem Pharm Bull (Tokyo); 2011; 59(2):155-60. PubMed ID: 21297292 [TBL] [Abstract][Full Text] [Related]
7. Assessment of Once Daily Controlled-release Ibuprofen Matrix Tablets Prepared using Eudragit Obeidat WM; Al-Natour MA Curr Drug Deliv; 2022; 19(1):74-85. PubMed ID: 34176461 [TBL] [Abstract][Full Text] [Related]
8. Enteric polymers as acidifiers for the pH-independent sustained delivery of a weakly basic drug salt from coated pellets. Körber M; Ciper M; Hoffart V; Pearnchob N; Walther M; Macrae RJ; Bodmeier R Eur J Pharm Biopharm; 2011 Aug; 78(3):447-54. PubMed ID: 21443950 [TBL] [Abstract][Full Text] [Related]
9. Novel Salted Anionic-Cationic Polymethacrylate Polymer Blends for Sustained Release of Acidic and Basic Drugs. Obeidat WM; Qasim D; Nokhodchi A; Al-Jabery A; Sallam AS Curr Drug Deliv; 2017; 14(1):109-122. PubMed ID: 27138298 [TBL] [Abstract][Full Text] [Related]
10. Eudraginated polymer blends: a potential oral controlled drug delivery system for theophylline. Emeje M; John-Africa L; Isimi Y; Kunle O; Ofoefule S Acta Pharm; 2012 Mar; 62(1):71-82. PubMed ID: 22472450 [TBL] [Abstract][Full Text] [Related]
12. Polymers with pH-dependent solubility: possibility of use in the formulation of gastroresistant and controlled-release matrix tablets. Palmieri GF; Michelini S; Di Martino P; Martelli S Drug Dev Ind Pharm; 2000 Aug; 26(8):837-45. PubMed ID: 10900540 [TBL] [Abstract][Full Text] [Related]
13. Eudragit-S, Eudragit-L and cellulose acetate phthalate coated polysaccharide tablets for colonic targeted delivery of azathioprine. Kotagale N; Maniyar M; Somvanshi S; Umekar M; Patel CJ Pharm Dev Technol; 2010; 15(4):431-7. PubMed ID: 20236031 [TBL] [Abstract][Full Text] [Related]
14. Properties of gastroretentive sustained release tablets prepared by combination of melt/sublimation actions of L-menthol and penetration of molten polymers into tablets. Fukuda M; Goto A Chem Pharm Bull (Tokyo); 2011; 59(10):1221-6. PubMed ID: 21963630 [TBL] [Abstract][Full Text] [Related]
15. High-amylose carboxymethyl starch matrices for oral sustained drug-release: in vitro and in vivo evaluation. Nabais T; Brouillet F; Kyriacos S; Mroueh M; Amores da Silva P; Bataille B; Chebli C; Cartilier L Eur J Pharm Biopharm; 2007 Mar; 65(3):371-8. PubMed ID: 17275270 [TBL] [Abstract][Full Text] [Related]
16. Influence of dissolution media composition on drug release and in-vitro/in-vivo correlation for paracetamol matrix tablets prepared with novel carbomer polymers. Parojcić J; Ethurić Z; Jovanović M; Ibrić S; Jovanović D J Pharm Pharmacol; 2004 Jun; 56(6):735-41. PubMed ID: 15231038 [TBL] [Abstract][Full Text] [Related]
17. Process optimization for continuous extrusion wet granulation. Tan L; Carella AJ; Ren Y; Lo JB Pharm Dev Technol; 2011 Aug; 16(4):302-15. PubMed ID: 20367553 [TBL] [Abstract][Full Text] [Related]
18. Influence of formulation and process variables on in vitro release of theophylline from directly-compressed Eudragit matrix tablets. Ceballos A; Cirri M; Maestrelli F; Corti G; Mura P Farmaco; 2005; 60(11-12):913-8. PubMed ID: 16129436 [TBL] [Abstract][Full Text] [Related]
19. Controlled release of a poorly water-soluble drug from hot-melt extrudates containing acrylic polymers. Zhu Y; Shah NH; Malick AW; Infeld MH; McGinity JW Drug Dev Ind Pharm; 2006 Jun; 32(5):569-83. PubMed ID: 16720412 [TBL] [Abstract][Full Text] [Related]
20. Sustained release dosage forms dissolution behavior prediction: a study of matrix tablets using NIR spectroscopy. Tabasi SH; Moolchandani V; Fahmy R; Hoag SW Int J Pharm; 2009 Dec; 382(1-2):1-6. PubMed ID: 19660535 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]